Estradiol(E2)

Reference ranges in healthy young men sit roughly between 20 and 40 pg/mL on ultra-sensitive assays. Estradiol below 10 to 15 pg/mL associates in observational data with reduced libido, joint pain, fatigue, and accelerated bone loss, often seen with aggressive aromatase inhibitor use during TRT. Persistently elevated estradiol above the upper reference limit in cycling men associates with gynecomastia, water retention, mood changes, and erectile dysfunction, although a substantial fraction of TRT patients tolerate higher levels without symptoms. The standard immunoassay used for female estradiol cross-reacts with estradiol metabolites at the lower concentrations typical of male serum, overestimating the true value by 30 to 100 percent. Ultra-sensitive estradiol by LC-MS/MS is the appropriate test in men, particularly on TRT, and an unexplained "high estradiol" result on a standard assay is often a measurement artifact rather than a clinical finding. Trial data on routine aromatase inhibition during TRT are mixed; many endocrinology groups now recommend treating symptoms rather than treating an estradiol number, and reserving anastrozole for confirmed symptomatic hyperestrogenism or persistent gynecomastia.